Jean-Pierre Sommadossi, President, CEO, and Chairman at Atea Pharmaceuticals, Inc. (AVIR), sold 114,097 shares at $4.03 ($461K) on 2024-09-18, disclosed to the SEC on 2024-09-19.
Scheduled sale ($461k) by President, CEO, and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.05 | 33,941 | $137K | 29.8% |
| 2 | $4.05 | 33,941 | $137K | 29.8% |
| 3 | $4.03 | 22,187 | $89K | 19.4% |
| 4 | $4.03 | 22,187 | $89K | 19.4% |
| 5 | $4.00 | 1,841 | $7K | 1.6% |
| Total | $4.04 avg | 114,097 |
| $461K |
| 100% |
| Filing → |
| IDIX | BUY | 2006-05-11 | $91K | — | Filing → |